griffonilide
CAS No. 61371-55-9
griffonilide ( —— )
Catalog No. M18901 CAS No. 61371-55-9
Griffonilide is an extract from the Semiaquilegia adoxoides root, a traditional anticancer herb.
Purity : 98%
Size | Price / USD | Stock | Quantity |
5MG | 101 | In Stock |
|
10MG | 149 | In Stock |
|
25MG | 249 | In Stock |
|
50MG | 357 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Namegriffonilide
-
NoteResearch use only, not for human use.
-
Brief DescriptionGriffonilide is an extract from the Semiaquilegia adoxoides root, a traditional anticancer herb.
-
DescriptionGriffonilide is an extract from the Semiaquilegia adoxoides root, a traditional anticancer herb.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61371-55-9
-
Formula Weight168.15
-
Molecular FormulaC8H8O4
-
Purity98%
-
Solubility——
-
SMILESO1C(=O)C=C2[C@H]1[C@H]([C@@H](C=C2)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
5-Hydroxy-7-(4-hydro...
5-Hydroxy-7-(4'-hydroxy-3'-methoxyphenyl)-1-phenyl-3-heptanone (DHPA) is a pancreatic lipase inhibitor, it shows antihyperlipidemic activity.
-
Hexa-D-arginine
Hexa-D-arginine?is an inhibitor of furinblocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?